Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by Bucknelly21on Sep 17, 2020 9:57pm
240 Views
Post# 31579225

Qwerty and jfm

Qwerty and jfm I highly respect both of your contributions clearly you guys are both very intelligent and so on and so forth, I must say however I think for either you to not think that thtx has thought through all of these doubts and questions you both are raising albeit valid would be a pretty low probability. Especially having basically the expert of Egrifta who has used it for years and years and dr. L who is basically the top nash person on planet earth. I'm sure he was paid for his time but for him to back such claims if he didn't believe in the drug would cost him far much more than whatever thtx paid him for his time if he were wrong. I just don't see that happening. It's not my optimism for the sp or whatever you might think, it's really common sense not to discredit your medical expertise but these guys probably know exactly what they are dealing with at this point without the questions you both raise on the board. I know there is a system that drugs must go through in order for you both to think it's going to work but this is a different situation. I almost feel as if you both are the science version of the analysts who can't comprehend how thtx could skip all the phases and now be in the running for possibly one of the first to market nash drugs. That's why they don't believe enough to assign a value to the nash program. It's doesn't make sense to them how this could happen, but it's not a new drug and it's extremely safe, safer than anything else for this out there period. No drug has that in this space period, I mean it may but they would need ten years to prove it. That means a lot in this process to the agencies. Especially for a unmet medical need. I mean no disrespect I respect both of your opinions very much 
Bullboard Posts